Provided by Tiger Trade Technology Pte. Ltd.

Praxis Precision Medicines, Inc.

295.51
+8.603.00%
Post-market: 295.510.00000.00%19:44 EDT
Volume:456.10K
Turnover:134.35M
Market Cap:8.23B
PE:-22.97
High:298.56
Open:290.13
Low:286.00
Close:286.91
52wk High:392.70
52wk Low:50.31
Shares:27.85M
Float Shares:24.08M
Volume Ratio:0.97
T/O Rate:1.89%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-12.8634
EPS(LYR):-13.4758
ROE:-38.86%
ROA:-25.65%
PB:6.14
PE(LYR):-21.93

Loading ...

Praxis Precision Med Price Target Maintained with a $810.00/Share by BTIG

Dow Jones
·
Jul 29

Praxis Precision Medicines (PRAX) Has a New Rating from Goldman Sachs

TIPRANKS
·
Jul 21

Praxis Precision Medicines (PRAX) Could Be 49% Undervalued As Patch Deal Expands Ulixacaltamide Reach

Simply Wall St.
·
Jul 20

Analysts Conflicted on These Healthcare Names: Alkermes (ALKS), TransMedics Group (TMDX) and Praxis Precision Medicines (PRAX)

TIPRANKS
·
Jul 14

Analysts Are Bullish on Top Healthcare Stocks: Praxis Precision Medicines (PRAX), Sino Biopharmaceutical (SBMFF)

TIPRANKS
·
Jul 13

Goldman Sachs Initiates Praxis Precision Medicines at Buy With $447 Price Target

MT Newswires Live
·
Jul 13

S&P 500 Futures Decline in Premarket Trading; SK Hynix ADR, MKS Lag

Dow Jones
·
Jul 13

Praxis Precision Med Initiated at Buy by Goldman Sachs

Dow Jones
·
Jul 13

Praxis Precision initiated with a Buy at Goldman Sachs

TIPRANKS
·
Jul 13

RBC Capital Remains a Buy on Praxis Precision Medicines (PRAX)

TIPRANKS
·
Jul 11

Can Praxis Precision Medicines (PRAX) Merit A Higher Valuation As It Expands Ulixacaltamide Delivery?

Simply Wall St.
·
Jul 10

Praxis Precision Medicines Seen Having Greater Commercial Upside for Relutrigine, RBC Says

MT Newswires Live
·
Jul 10

Praxis Precision, Remagine Labs Partner on Ulixacaltamide Patch

TIPRANKS
·
Jul 08

Praxis Precision Medicines Makes Equity Investment in Remagine Labs

Reuters
·
Jul 07

Praxis Precision Medicines and Remagine Labs Announce Strategic Collaboration to Develop Transdermal Ulixacaltamide for Essential Tremor

THOMSON REUTERS
·
Jul 07

S&P 500 Futures Climb in Premarket Trading; Praxis Precision Meds, IREN Lead

Dow Jones
·
Jul 06

Praxis Precision Medicines Switches Auditor to KPMG from EY

Reuters
·
Jul 03

Praxis Precision Medicines Grants 951 Restricted Stock Units to Five New Employees Under Inducement Plan

Reuters
·
Jul 03

Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
Jul 03

Movement Alert|Praxis Precision Medicines Falls 5.15% in Regular Trading, FDA Extends Relutrigine Review Period by Three Months

Market Focus
·
Jul 02